~63 spots leftby Apr 2026

mHealth Mood Management Tool (Actify) to Improve Population-Level Smoking Cessation

Recruiting in Palo Alto (17 mi)
JH
Overseen byJaimee Heffner
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 1
Waitlist Available
Sponsor: Fred Hutchinson Cancer Research Center
No Placebo Group

Trial Summary

What is the purpose of this trial?

This phase I trial investigates a new smartphone application (called Actify) for improving population-level smoking cessation and mood management. Actify delivers behavioral activation therapy for depression as part of a smoking cessation intervention and will be compared to another smoking cessation smartphone application that is based on current clinical practice guidelines. Participants will be randomly assigned to receive one of two smartphone applications and accompanying text notifications to help with quitting smoking and improved mood.

Research Team

JH

Jaimee Heffner

Principal Investigator

Fred Hutch/University of Washington Cancer Consortium

Eligibility Criteria

Inclusion Criteria

You smoke at least five cigarettes a day for the past month.
You plan to stop smoking within the next month.
You have used at least one app on your smartphone before.
See 3 more

Exclusion Criteria

You are currently receiving therapy for depression, such as talking to a therapist.
You are currently using an app to manage depression.
You have very severe depression with a score of 20 or higher on the PHQ-9 questionnaire.
See 6 more

Treatment Details

Interventions

  • Actify (Behavioural Intervention)
  • Current Standard Care app (Behavioural Intervention)
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Arm I (Actify, text notifications)Experimental Treatment3 Interventions
Participants use Actify app for smoking cessation for 8 weeks. Participants also receive motivational messages and smoking cessation information via text notifications.
Group II: Arm II (Current Standard Care, text notifications)Active Control3 Interventions
Participants use app for smoking cessation for 8 weeks. Participants also receive motivational messages and smoking cessation information via text notifications.

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
Fred Hutch/University of Washington Cancer ConsortiumSeattle, WA
Loading ...

Who Is Running the Clinical Trial?

Fred Hutchinson Cancer Research Center

Lead Sponsor

Trials
444
Recruited
148,000+
Dr. Nancy Davidson profile image

Dr. Nancy Davidson

Fred Hutchinson Cancer Research Center

Chief Medical Officer since 2020

MD from Harvard Medical School

Dr. Thomas J. Lynch Jr. profile image

Dr. Thomas J. Lynch Jr.

Fred Hutchinson Cancer Research Center

Chief Executive Officer since 2020

MD from Yale University, BA from Yale College

Fred Hutchinson Cancer Center

Lead Sponsor

Trials
583
Recruited
1,341,000+
Dr. W. Thomas Purcell profile image

Dr. W. Thomas Purcell

Fred Hutchinson Cancer Center

Chief Medical Officer since 2022

MD from Emory University School of Medicine, MBA from University of Chicago

Dr. Thomas J. Lynch Jr. profile image

Dr. Thomas J. Lynch Jr.

Fred Hutchinson Cancer Center

Chief Executive Officer since 2020

MD from Yale School of Medicine

National Institute on Drug Abuse (NIDA)

Collaborator

Trials
2,658
Recruited
3,409,000+
Dr. Nora Volkow profile image

Dr. Nora Volkow

National Institute on Drug Abuse (NIDA)

Chief Executive Officer since 2003

MD from National Autonomous University of Mexico

Dr. Nora Volkow profile image

Dr. Nora Volkow

National Institute on Drug Abuse (NIDA)

Chief Medical Officer since 2003

MD from National Autonomous University of Mexico